These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 28724841)
21. Apolipoprotein M Inhibits Angiogenic and Inflammatory Response by Sphingosine 1-Phosphate on Retinal Pigment Epithelium Cells. Terao R; Honjo M; Aihara M Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29301231 [TBL] [Abstract][Full Text] [Related]
22. Regulation of the metabolism of apolipoprotein M and sphingosine 1-phosphate by hepatic PPARγ activity. Kurano M; Ikeda H; Iso-O N; Hara M; Tsukamoto K; Yatomi Y Biochem J; 2018 Jun; 475(12):2009-2024. PubMed ID: 29712716 [TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein M Protects Lipopolysaccharide-Treated Mice from Death and Organ Injury. Kurano M; Tsuneyama K; Morimoto Y; Shimizu T; Jona M; Kassai H; Nakao K; Aiba A; Yatomi Y Thromb Haemost; 2018 Jun; 118(6):1021-1035. PubMed ID: 29669385 [TBL] [Abstract][Full Text] [Related]
24. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism. Karuna R; Park R; Othman A; Holleboom AG; Motazacker MM; Sutter I; Kuivenhoven JA; Rohrer L; Matile H; Hornemann T; Stoffel M; Rentsch KM; von Eckardstein A Atherosclerosis; 2011 Dec; 219(2):855-63. PubMed ID: 21944699 [TBL] [Abstract][Full Text] [Related]
25. A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex. Frej C; Mendez AJ; Ruiz M; Castillo M; Hughes TA; Dahlbäck B; Goldberg RB Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1194-1205. PubMed ID: 28385702 [TBL] [Abstract][Full Text] [Related]
26. Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons. Frej C; Linder A; Happonen KE; Taylor FB; Lupu F; Dahlbäck B J Cell Mol Med; 2016 Jun; 20(6):1170-81. PubMed ID: 26990127 [TBL] [Abstract][Full Text] [Related]
27. Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice. Obinata H; Kuo A; Wada Y; Swendeman S; Liu CH; Blaho VA; Nagumo R; Satoh K; Izumi T; Hla T J Lipid Res; 2019 Nov; 60(11):1912-1921. PubMed ID: 31462513 [TBL] [Abstract][Full Text] [Related]
28. An engineered S1P chaperone attenuates hypertension and ischemic injury. Swendeman SL; Xiong Y; Cantalupo A; Yuan H; Burg N; Hisano Y; Cartier A; Liu CH; Engelbrecht E; Blaho V; Zhang Y; Yanagida K; Galvani S; Obinata H; Salmon JE; Sanchez T; Di Lorenzo A; Hla T Sci Signal; 2017 Aug; 10(492):. PubMed ID: 28811382 [TBL] [Abstract][Full Text] [Related]
29. High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate. Brinck JW; Thomas A; Brulhart-Meynet MC; Lauer E; Frej C; Dahlbäck B; Stenvinkel P; James RW; Frias MA Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29178180 [TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein. Velagapudi S; Rohrer L; Poti F; Feuerborn R; Perisa D; Wang D; Panteloglou G; Potapenko A; Yalcinkaya M; Hülsmeier AJ; Hesse B; Lukasz A; Liu M; Parks JS; Christoffersen C; Stoffel M; Simoni M; Nofer JR; von Eckardstein A Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):e468-e479. PubMed ID: 34407633 [TBL] [Abstract][Full Text] [Related]
31. Regulation of the apolipoprotein M signaling pathway: a review. Cheng G; Zheng L J Recept Signal Transduct Res; 2022 Jun; 42(3):285-292. PubMed ID: 34006168 [TBL] [Abstract][Full Text] [Related]
32. A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation. Hajny S; Christoffersen C Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28749426 [TBL] [Abstract][Full Text] [Related]
33. Induction of insulin secretion by apolipoprotein M, a carrier for sphingosine 1-phosphate. Kurano M; Hara M; Tsuneyama K; Sakoda H; Shimizu T; Tsukamoto K; Ikeda H; Yatomi Y Biochim Biophys Acta; 2014 Sep; 1841(9):1217-26. PubMed ID: 24814049 [TBL] [Abstract][Full Text] [Related]
34. Effect of menopause and exercise training on plasma apolipoprotein M and sphingosine-1-phosphate. Yafasova A; Mandrup CM; Egelund J; Nyberg M; Stallknecht B; Hellsten Y; Nielsen LB; Christoffersen C J Appl Physiol (1985); 2019 Jan; 126(1):214-220. PubMed ID: 30433864 [TBL] [Abstract][Full Text] [Related]
35. Binding Characteristics of Sphingosine-1-Phosphate to ApoM hints to Assisted Release Mechanism via the ApoM Calyx-Opening. Zhang H; Pluhackova K; Jiang Z; Böckmann RA Sci Rep; 2016 Aug; 6():30655. PubMed ID: 27476912 [TBL] [Abstract][Full Text] [Related]
36. Plasma apoM and S1P levels are inversely associated with mortality in African Americans with type 2 diabetes mellitus. Liu M; Frej C; Langefeld CD; Divers J; Bowden DW; Carr JJ; Gebre AK; Xu J; Larsson B; Dahlbäck B; Freedman BI; Parks JS J Lipid Res; 2019 Aug; 60(8):1425-1431. PubMed ID: 31133557 [TBL] [Abstract][Full Text] [Related]
37. Protection Against Insulin Resistance by Apolipoprotein M/Sphingosine-1-Phosphate. Kurano M; Tsukamoto K; Shimizu T; Kassai H; Nakao K; Aiba A; Hara M; Yatomi Y Diabetes; 2020 May; 69(5):867-881. PubMed ID: 31915150 [TBL] [Abstract][Full Text] [Related]
38. Uncleaved ApoM signal peptide is required for formation of large ApoM/sphingosine 1-phosphate (S1P)-enriched HDL particles. Liu M; Allegood J; Zhu X; Seo J; Gebre AK; Boudyguina E; Cheng D; Chuang CC; Shelness GS; Spiegel S; Parks JS J Biol Chem; 2015 Mar; 290(12):7861-70. PubMed ID: 25627684 [TBL] [Abstract][Full Text] [Related]